Reklama
twitter
youtube
facebook
instagram
linkedin
Reklama
Reklama

Sopharma AD: Current report 37 re insiders transactions (2016-04-18)

|
selectedselectedselected
Reklama
Aa
Udostępnij
facebook
twitter
linkedin
wykop

UNI-EN 37:SPHTRCurrent report 37 re insiders transactions

Firma: SOPHARMA AD
Spis treści:
1. REPORT
2. INFORMATION ABOUT THE ENTITY
3. SIGNATURE OF PERSONS REPRESENTING THE COMPANY

Spis załączników:
  1. SPHTRCurrent report 37 re insiders transactions.doc SPHTRCurrent report 37 re insiders transactions

POLISH FINANCIAL SUPERVISION AUTHORITY









UNI - EN REPORT No 37 / 2016





Date of issue: 2016-04-18
Short name of the issuer
SOPHARMA AD
Subject
SPHTRCurrent report 37 re insiders transactions
Official market - legal basis
Art. 160 ust 4 Ustawy o obrocie - informacja o transakcjach osуb maj№cych dostкp do informacji poufnych
Unofficial market - legal basis
Contents of the report:
Sopharma AD (the “Company") announces that it was notified by Mr. Ognian Donev, Chairman of the Board of Directors that the company “Sopharma Trading AD" related to him, executed the following transactions related to shares in the Company:


Date and time of the settlement Operation Number of shares Unit price (BGN)
6.4.2016 Buy 200 2.6900
6.4.2016 Buy 900 2.7000
6.4.2016 Buy 500 2.7000
6.4.2016 Buy 500 2.7000
6.4.2016 Buy 500 2.7000
6.4.2016 Buy 800 2.7000
6.4.2016 Buy 240 2.7000
7.4.2016 Buy 80 2.6800
7.4.2016 Buy 1 500 2.6900
7.4.2016 Buy 500 2.6900
7.4.2016 Buy 325 2.6650
7.4.2016 Buy 110 2.6650
8.4.2016 Buy 500 2.6650
11.4.2016 Buy 500 2.6930
12.4.2016 Buy 100 2.6900
12.4.2016 Buy 400 2.6900
12.4.2016 Buy 500 2.6800
31.3.2016 Buy 200 2.7000
31.3.2016 Buy 149 2.7040
31.3.2016 Buy 200 2.7000
1.4.2016 Buy 220 2.7000
1.4.2016 Buy 200 2.7000
1.4.2016 Buy 100 2.7000
1.4.2016 Buy 200 2.7000
1.4.2016 Buy 200 2.7000
1.4.2016 Buy 100 2.7000
1.4.2016 Buy 100 2.7000
1.4.2016 Buy 200 2.7000
1.4.2016 Buy 200 2.7000
1.4.2016 Buy 200 2.7000
1.4.2016 Buy 200 2.7000
1.4.2016 Buy 96 2.7000
1.4.2016 Buy 250 2.6950
1.4.2016 Buy 500 2.6850
1.4.2016 Buy 250 2.6850
1.4.2016 Buy 195 2.6850
4.4.2016 Buy 500 2.6850
4.4.2016 Buy 160 2.6850
4.4.2016 Buy 340 2.6850
5.4.2016 Buy 69 2.6950
13.4.2016 Buy 200 2.6700
13.4.2016 Buy 115 2.6600
13.4.2016 Buy 65 2.6650
13.4.2016 Buy 385 2.6600
18.4.2016 Buy 500 2.6800
18.4.2016 Buy 100 2.6770
18.4.2016 Buy 500 2.6700
18.4.2016 Buy 135 2.6300
18.4.2016 Buy 500 2.6300
19.4.2016 Buy 320 2.6700


The transfer of the above-mentioned shares was executed on the Bulgarian Stock Exchange in Sofia (regulated market) by way of electronic trade.
Annexes
File Description
SPHTRCurrent report 37 re insiders transactions.doc
SPHTRCurrent report 37 re insiders transactions.doc
SPHTRCurrent report 37 re insiders transactions

SOPHARMA AD
(fullname of the issuer)
SOPHARMA AD Farmaceutyczny (far)
(short name of the issuer) (sector according to clasification
of the WSE in Warsow)
1220 Sofia
(post code) (city)
IlienskoShosse 16
(street) (number)
+359 2 813 42 00 +359 2 936 02 86
(phone number) (fax)
(e-mail) (web site)
nd
(NIP) (REGON)

SIGNATURE OF PERSONS REPRESENTING THE COMPANY
Date Name Position / Function Signature
2016-04-18 Ognian Donev Executive director

Cena akcji Sopharma

Cena akcji Sopharma w momencie publikacji komunikatu to 5.42 PLN. Sprawdź ile kosztuje akcja Sopharma aktualnie.

W tej sekcji znajdziesz wszystkie komunikaty ESPI EBI Sopharma.

Jesteś dziennikarzem i szukasz pracy? Napisz do nas

Masz lekkie pióro? Interesujesz się gospodarką i finansami? Możliwe, że szukamy właśnie Ciebie.

Zgłoś swoją kandydaturę

Reklama